The core of TaurGen’s proprietary platform of human mAb production is the following:
- A universal gene knock-in vector, assisted by programmable endonuclease-mediated genome engineering technology, to precisely engineer the cDNAs of mAbs along with TaurGen’s proprietary gene expression enhancer sequences into the selected loci of animal genome to render high levels of expression of mAbs in a tissue specific manner
- A family of intellectual property on methods of use and material compositions in cloning GE large animals as bioreactors
- Proprietary mAbs developed in-house
